OCUL - OCULAR THERAPEUTIX, INC
IEX Last Trade
8.55
-0.040 -0.468%
Share volume: 11,956
Last Updated: Fri 27 Dec 2024 02:30:10 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.34%
PREVIOUS CLOSE
CHG
CHG%
$8.59
-0.04
-0.47%
Summary score
28%
Profitability
25%
Dept financing
43%
Liquidity
75%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-105.79%
Return on assets
-11.18%
Return on sales
-232.81%
Return on invested capital
153.22%
Total debt ratio
72.36%
Debt ratio change over timeo
0.61%
Current Ratio
7.15%
Quick Ratio
7.09%
Cash Position Ratio
6.23%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-181.13%
Return on assets
-10.61%
Return on sales
-153.08%
Return on invested capital
411.86%
Total debt ratio
70.2%
Debt ratio change over timeo
5.61%
Current Ratio
8.8%
Quick Ratio
8.72%
Cash Position Ratio
7.67%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-15.89%
Return on assets
-5.87%
Return on sales
-214%
Return on invested capital
1253.1%
Total debt ratio
24.3%
Debt ratio change over time
-0.87%
Current Ratio
21.39%
Quick Ratio
21.29%
Cash Position Ratio
19.87%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-102.84%
Return on assets
-121.98%
Return on sales
-297.69%
Return on invested capital
-221.41%
Total debt ratio
60.79%
Debt ratio change over time
0.61%
Current Ratio
5.07%
Quick Ratio
4.95%
Cash Position Ratio
3.5%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | OCUL | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -105.79% | 18.83% | 17.34% | 7.6% |
| Return on assets | -11.18% | 4.16% | 8.21% | 3.22% |
| Return on sales | -232.81% | 28.21% | 41.18% | 25.37% |
| Return on invested capital | 153.22% | 9.79% | -219.55% | 7.46% |
| Profitability | 25% | 56% | 73% | 37% |
| Total debt ratio | 72.36% | 82.89% | 55.88% | 60.02% |
| Debt ratio change over time | 0.61% | -4.38% | -0.73% | -33.74% |
| Dept financing | 47% | 25% | 17% | 18% |
| Current Ratio | 8.8% | 1.12% | 0% | 1.16% |
| Quick Ratio | 8.72% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 7.67% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 8% | 8% | 10% |
| Short-term ratios | OCUL | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -181.13% | 13.31% | 0% | 13.48% |
| Return on assets | -10.61% | 4.72% | 0% | 3.05% |
| Return on sales | -153.08% | 31.4% | 0% | 25.56% |
| Return on invested capital | 411.86% | 10.68% | 0% | 13.96% |
| Profitability | 25% | 75% | 0% | 62% |
| Total debt ratio | 70.2% | 80.89% | 0% | 59.04% |
| Debt ratio change over time | 5.61% | -41.82% | 0% | 7.13% |
| Dept financing | 41% | 25% | 0% | 43% |
| Current Ratio | 8.8% | 1.12% | 0% | 1.16% |
| Quick Ratio | 8.72% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 7.67% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 6% | 0% | 8% |